SCHEMBL31495655

SCHEMBL31495655

C[C@@H]1CN(C(=O)OCc2ccccc2)CCN1C(CO)C(F)(F)F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.54
PDK2 Q15119 1/20 0.54
PDK3 Q15120 1/20 0.54
PDK4 Q16654 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
HTT P42858 1/20 0.45
HTR2C P28335 2/20 0.45
CYP2C19 P33261 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RORC P51449 2/20 0.41
MMP1 P03956 1/20 0.41
MMP3 P08254 1/20 0.41
MMP7 P09237 1/20 0.41
MMP9 P14780 1/20 0.41
MMP13 P45452 1/20 0.41
NR1H2 P55055 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3868582 0.83 PDK1 (0.53) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL3863607 0.83 PDK1 (0.53) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL29277598 0.80 PDK1 (0.50) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL29849418 0.77 CHRM1 (0.60) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL4329059 0.77 PDK1 (0.71) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL30524578 0.77 CHRM1 (0.60) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL13169241 0.77 CCR5 (0.51) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL31393228 0.75 HTR2C (0.58) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL3662621 0.75 HTR2C (0.58) PDK1PDK2PDK3PDK4SMN1; SMN2
SCHEMBL4329419 0.75 PDK1 (0.56) PDK1PDK2PDK3PDK4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4549438-A1 FIVE-MEMBERED AND SIX-MEMBERED NITROGEN-CONTAINING COMPOUND, AND INTERMEDIATE, PREPARATION METHOD AND USE THEREOF Hangzhou Synrx Therapeutics Biomedical Technology Co., Ltd. (CN) 2025-05-07 EP disclosed